Health Coaching, Continuous Glucose Monitoring and AI Mobile App in Diabetes
Continuous Assessment of Risk and Efficacy (CARE) Using Health Coaching, Continuous Glucose Monitoring and AI Mobile App in Diabetes
Singapore General Hospital
400 participants
Oct 24, 2023
INTERVENTIONAL
Conditions
Summary
Lifestyle change is key to diabetes management but there are limited resources and time to support patients in improving lifestyle behaviour in the current healthcare system. Currently, health coaching for behavioural chance guided by continuous glucose data, wearable and lifestyle data is not available in primary and tertiary care management of diabetes. This parallel-group randomised controlled trial (RCT) aims to investigate the effectiveness of a novel multi-component model of care comprising interventions including the mobile app EMPOWER and smartwatch, health coaching, and continuous glucose monitoring (CGM).
Eligibility
Inclusion Criteria5
- Aged 21 years and above
- Have diagnosis of type 2 diabetes mellitus
- Provided informed consent
- Have near-field communication (NFC) compatible phones
- Able to engage in light physical activity (e.g., walking)
Exclusion Criteria2
- Significant cognitive impairment
- Other conditions that may preclude participants from wearing CGM devices
Interventions
Each CGM device will work for 14 days. The participants will use the CGM devices for the first two-week period in the first three months of the trial, and the first two-week period of the second three months of the trial. Participants will interact with health coach throughout the study duration.
Nudges will be delivered through the EMPOWER mobile app. Participants will log lifestyle information such as diet and physical activity, and clinical information such as medication and HbA1c levels through the EMPOWER mobile app.
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06028139